Chemours Co
For the period ended Sep 30, 2024. Filed Nov 4, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2024 · Filed Nov 4, 2024
CC$13.48+1.5%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Interim Consolidated Balance Sheets (Unaudited)
| September 30, 2024 | December 31, 2023 | |
|---|---|---|
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $596 | $1,203 |
| Restricted cash and restricted cash equivalents | 20 | 604 |
| Accounts and notes receivable, net | 951 | 610 |
| Inventories | 1,438 | 1,352 |
| Prepaid expenses and other | 75 | 66 |
| Total current assets | 3,080 | 3,835 |
| Property, plant, and equipment | 9,545 | 9,412 |
| Less: Accumulated depreciation | (6,372) | (6,196) |
| Property, plant, and equipment, net | 3,173 | 3,216 |
| Operating lease right-of-use assets | 254 | 260 |
| Goodwill | 46 | 102 |
| Other intangible assets, net | 3 | 3 |
| Investments in affiliates | 190 | 158 |
| Restricted cash and restricted cash equivalents | 50 | — |
| Other assets | 667 | 677 |
| Total assets | $7,463 | $8,251 |
| Liabilities | ||
| Current liabilities: | ||
| Accounts payable | $1,069 | $1,159 |
| Compensation and other employee-related cost | 89 | 89 |
| Short-term and current maturities of long-term debt | 53 | 51 |
| Current environmental remediation | 119 | 129 |
| Other accrued liabilities | 447 | 1,058 |
| Total current liabilities | 1,777 | 2,486 |
| Long-term debt, net | 3,988 | 3,987 |
| Operating lease liabilities | 196 | 206 |
| Long-term environmental remediation | 448 | 461 |
| Deferred income taxes | 41 | 44 |
| Other liabilities | 354 | 328 |
| Total liabilities | 6,804 | 7,512 |
| Commitments and contingent liabilities | ||
| Equity | ||
| Common stock (par value $0.01 per share; 810,000,000 shares authorized; 198,282,108 shares issued and 149,392,660 shares outstanding at September 30, 2024; 197,519,784 shares issued and 148,587,397 shares outstanding at December 31, 2023) | 2 | 2 |
| Treasury stock, at cost (48,889,448 shares at September 30, 2024 and 48,932,387 at December 31, 2023) | (1,805) | (1,806) |
| Additional paid-in capital | 1,050 | 1,033 |
| Retained earnings | 1,763 | 1,782 |
| Accumulated other comprehensive loss | (353) | (274) |
| Total Chemours stockholders’ equity | 657 | 737 |
| Non-controlling interests | 2 | 2 |
| Total equity | 659 | 739 |
| Total liabilities and equity | $7,463 | $8,251 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.